Sofía de la Villa

TL;DR: This work describes eight CAPA patients, compares them to colonised ICU patients with coronavirus disease 2019 (COVID‐19), and reviews the published literature from Western countries.

TL;DR: Wang et al. as mentioned in this paper collected data from 186 patients who had coronavirus disease-associated pulmonary aspergillosis (CAPA) worldwide during March-August 2020, and found that the cumulative incidence of CAPA in the ICU ranged from 1.0% to 39.1%.

TL;DR: In this article , the authors describe a cohort of patients with a constellation of symptoms occurring four weeks after diagnosis causing different degrees of reduced functional capacity, and they were offered antiviral treatment (compassionate use).

TL;DR: In this article, the authors report two cases of heart and liver recipients from a donor with previous documented COVID-19 and positive RT-PCR at time of transplantation.

TL;DR: The prevalence of DM among patients with IE is increasing and is already above 30%.